Logo image of BAMI.MI

BANCO BPM SPA (BAMI.MI) Stock Fundamental Analysis

BIT:BAMI - Euronext Milan - IT0005218380 - Common Stock - Currency: EUR

9.738  +0.21 (+2.18%)

Fundamental Rating

3

Overall BAMI gets a fundamental rating of 3 out of 10. We evaluated BAMI against 95 industry peers in the Banks industry. Both the profitability and financial health of BAMI have multiple concerns. BAMI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

BAMI had positive earnings in the past year.
BAMI had a negative operating cash flow in the past year.
BAMI had positive earnings in each of the past 5 years.
In multiple years BAMI reported negative operating cash flow during the last 5 years.
BAMI.MI Yearly Net Income VS EBIT VS OCF VS FCFBAMI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

1.2 Ratios

With an excellent Return On Assets value of 1.63%, BAMI belongs to the best of the industry, outperforming 92.63% of the companies in the same industry.
BAMI has a better Return On Equity (22.16%) than 97.89% of its industry peers.
Industry RankSector Rank
ROA 1.63%
ROE 22.16%
ROIC N/A
ROA(3y)0.65%
ROA(5y)0.45%
ROE(3y)9.14%
ROE(5y)6.39%
ROIC(3y)N/A
ROIC(5y)N/A
BAMI.MI Yearly ROA, ROE, ROICBAMI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

The Profit Margin of BAMI (22.34%) is comparable to the rest of the industry.
BAMI's Profit Margin has been stable in the last couple of years.
The Operating Margin and Gross Margin are not available for BAMI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 22.34%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y9.18%
PM growth 5Y1.2%
GM growth 3YN/A
GM growth 5YN/A
BAMI.MI Yearly Profit, Operating, Gross MarginsBAMI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

1

2. Health

2.1 Basic Checks

BAMI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BAMI has less shares outstanding
The number of shares outstanding for BAMI has been reduced compared to 5 years ago.
Compared to 1 year ago, BAMI has a worse debt to assets ratio.
BAMI.MI Yearly Shares OutstandingBAMI.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
BAMI.MI Yearly Total Debt VS Total AssetsBAMI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

A Debt/Equity ratio of 2.09 is on the high side and indicates that BAMI has dependencies on debt financing.
BAMI has a Debt to Equity ratio of 2.09. This is comparable to the rest of the industry: BAMI outperforms 48.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.09
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.38%
BAMI.MI Yearly LT Debt VS Equity VS FCFBAMI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BAMI.MI Yearly Current Assets VS Current LiabilitesBAMI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

5

3. Growth

3.1 Past

BAMI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.43%, which is quite impressive.
Measured over the past years, BAMI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.15% on average per year.
Looking at the last year, BAMI shows a quite strong growth in Revenue. The Revenue has grown by 17.68% in the last year.
Measured over the past years, BAMI shows a quite strong growth in Revenue. The Revenue has been growing by 17.82% on average per year.
EPS 1Y (TTM)51.43%
EPS 3Y49.52%
EPS 5Y19.15%
EPS Q2Q%-28.57%
Revenue 1Y (TTM)17.68%
Revenue growth 3Y37.38%
Revenue growth 5Y17.82%
Sales Q2Q%2.68%

3.2 Future

BAMI is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.44% yearly.
BAMI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.68% yearly.
EPS Next Y-14.62%
EPS Next 2Y-6.68%
EPS Next 3Y-2.44%
EPS Next 5YN/A
Revenue Next Year-1.21%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.68%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BAMI.MI Yearly Revenue VS EstimatesBAMI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
BAMI.MI Yearly EPS VS EstimatesBAMI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.67, the valuation of BAMI can be described as very cheap.
Based on the Price/Earnings ratio, BAMI is valued a bit cheaper than the industry average as 71.58% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of BAMI to the average of the S&P500 Index (28.79), we can say BAMI is valued rather cheaply.
The Price/Forward Earnings ratio is 8.97, which indicates a very decent valuation of BAMI.
The rest of the industry has a similar Price/Forward Earnings ratio as BAMI.
BAMI is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.67
Fwd PE 8.97
BAMI.MI Price Earnings VS Forward Price EarningsBAMI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BAMI.MI Per share dataBAMI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

A cheap valuation may be justified as BAMI's earnings are expected to decrease with -2.44% in the coming years.
PEG (NY)N/A
PEG (5Y)0.4
EPS Next 2Y-6.68%
EPS Next 3Y-2.44%

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.78%, BAMI is a good candidate for dividend investing.
BAMI's Dividend Yield is rather good when compared to the industry average which is at 5.47. BAMI pays more dividend than 100.00% of the companies in the same industry.
BAMI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 10.78%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

BAMI pays out 44.76% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP44.76%
EPS Next 2Y-6.68%
EPS Next 3Y-2.44%
BAMI.MI Yearly Income VS Free CF VS DividendBAMI.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B
BAMI.MI Dividend Payout.BAMI.MI Dividend Payout, showing the Payout Ratio.BAMI.MI Dividend Payout.PayoutRetained Earnings

More info and screens

BANCO BPM SPA

BIT:BAMI (4/25/2025, 7:00:00 PM)

9.738

+0.21 (+2.18%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)02-12 2025-02-12/dmh
Earnings (Next)05-07 2025-05-07
Inst Owners39.25%
Inst Owner ChangeN/A
Ins Owners2.15%
Ins Owner ChangeN/A
Market Cap14.75B
Analysts74
Price Target10.15 (4.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.78%
Yearly Dividend0.96
Dividend Growth(5Y)N/A
DP44.76%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)63.66%
Min EPS beat(2)-22.6%
Max EPS beat(2)149.92%
EPS beat(4)2
Avg EPS beat(4)50.19%
Min EPS beat(4)-22.6%
Max EPS beat(4)149.92%
EPS beat(8)6
Avg EPS beat(8)31.94%
EPS beat(12)9
Avg EPS beat(12)25.53%
EPS beat(16)13
Avg EPS beat(16)35.9%
Revenue beat(2)2
Avg Revenue beat(2)2.91%
Min Revenue beat(2)1.65%
Max Revenue beat(2)4.16%
Revenue beat(4)3
Avg Revenue beat(4)1.22%
Min Revenue beat(4)-0.98%
Max Revenue beat(4)4.16%
Revenue beat(8)6
Avg Revenue beat(8)0.85%
Revenue beat(12)10
Avg Revenue beat(12)23.76%
Revenue beat(16)14
Avg Revenue beat(16)19.82%
PT rev (1m)7.88%
PT rev (3m)25.32%
EPS NQ rev (1m)10%
EPS NQ rev (3m)N/A
EPS NY rev (1m)5.58%
EPS NY rev (3m)17.34%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.34%
Valuation
Industry RankSector Rank
PE 7.67
Fwd PE 8.97
P/S 1.02
P/FCF N/A
P/OCF N/A
P/B 1.01
P/tB 1.11
EV/EBITDA N/A
EPS(TTM)1.27
EY13.04%
EPS(NY)1.09
Fwd EY11.15%
FCF(TTM)-3.4
FCFYN/A
OCF(TTM)-3.23
OCFYN/A
SpS9.56
BVpS9.64
TBVpS8.81
PEG (NY)N/A
PEG (5Y)0.4
Profitability
Industry RankSector Rank
ROA 1.63%
ROE 22.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 22.34%
GM N/A
FCFM N/A
ROA(3y)0.65%
ROA(5y)0.45%
ROE(3y)9.14%
ROE(5y)6.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y9.18%
PM growth 5Y1.2%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 2.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC5.38%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)3.42%
Cap/Sales(5y)3.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.43%
EPS 3Y49.52%
EPS 5Y19.15%
EPS Q2Q%-28.57%
EPS Next Y-14.62%
EPS Next 2Y-6.68%
EPS Next 3Y-2.44%
EPS Next 5YN/A
Revenue 1Y (TTM)17.68%
Revenue growth 3Y37.38%
Revenue growth 5Y17.82%
Sales Q2Q%2.68%
Revenue Next Year-1.21%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.68%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-190.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-182.96%
OCF growth 3YN/A
OCF growth 5YN/A